Literature DB >> 32002807

Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism.

Namita Ganesh Hattangady1,2, Jessica Foster1, Antonio Marcondes Lerario1, Daniela Ponce-Balbuena3, Juilee Rege4, Silvia Monticone5, William E Rainey1,4, Paolo Mulatero4, Tobias Else6.   

Abstract

Primary aldosteronism (PA) is the most common cause of secondary hypertension with a high prevalence among patients with resistant hypertension. Despite the recent discovery of somatic variants in aldosterone-producing adenoma (APA)-associated PA, causes for PA due to bilateral aldosterone production (bilateral hyperaldosteronism; BHA) remain unknown. Herein, we identified rare gene variants in ATP2B4, in a cohort of patients with BHA. ATP2B4 belongs to the same family of Ca-ATPases as ATP2B3, which is involved in the pathogenesis of APA. Endogenous ATP2B4 expression was characterized in adrenal tissue, and the gene variants were functionally analyzed for effects on aldosterone synthase (CYP11B2) expression, steroid production in basal and agonist-stimulated conditions, and for changes in biophysical properties of channel properties. Knockdown of ATP2B4 in HAC15 exhibited reduced angiotensin II stimulation in one of four shRNA clones. Stable HAC15 cell lines with doxycycline (dox) - inducible wild-type and variant forms of ATP2B4 - were generated, and dox-induced upregulation of ATP2B4 mRNA and protein was confirmed. However, ATP2B4 variants did not alter basal or agonist-stimulated CYP11B2 expression. Whole-cell recordings in HAC15 cells indicated robust endogenous ATP2B4 conductance in native cells but reduced conductance with overexpressed WT and variant ATP2B4. The previously defined PA-causing ATP2B3 variant served as a positive control and exhibited elevated CYP11B2 mRNA. In conclusion, while this study did not confirm a pathogenic role for ATP2B4 variants in BHA, we describe the sequencing analysis for familial and sporadic BHA and outline a template for the thorough in vitro characterization of gene variants.

Entities:  

Keywords:  ATP2B3; ATP2B4; Aldosterone; Ca-ATPases; Doxycycline-inducible expression; Primary aldosteronism

Mesh:

Substances:

Year:  2020        PMID: 32002807      PMCID: PMC8018534          DOI: 10.1007/s12672-019-00375-0

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  43 in total

1.  The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme.

Authors:  R Falchetto; T Vorherr; E Carafoli
Journal:  Protein Sci       Date:  1992-12       Impact factor: 6.725

2.  A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism.

Authors:  Fabio L Fernandes-Rosa; Georgios Daniil; Ian J Orozco; Corinna Göppner; Rami El Zein; Vandana Jain; Sheerazed Boulkroun; Xavier Jeunemaitre; Laurence Amar; Hervé Lefebvre; Thomas Schwarzmayr; Tim M Strom; Thomas J Jentsch; Maria-Christina Zennaro
Journal:  Nat Genet       Date:  2018-02-05       Impact factor: 38.330

Review 3.  Calcium pumps in health and disease.

Authors:  Marisa Brini; Ernesto Carafoli
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

4.  Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.

Authors:  Felix Beuschlein; Sheerazed Boulkroun; Andrea Osswald; Thomas Wieland; Hang N Nielsen; Urs D Lichtenauer; David Penton; Vivien R Schack; Laurence Amar; Evelyn Fischer; Anett Walther; Philipp Tauber; Thomas Schwarzmayr; Susanne Diener; Elisabeth Graf; Bruno Allolio; Benoit Samson-Couterie; Arndt Benecke; Marcus Quinkler; Francesco Fallo; Pierre-Francois Plouin; Franco Mantero; Thomas Meitinger; Paolo Mulatero; Xavier Jeunemaitre; Richard Warth; Bente Vilsen; Maria-Christina Zennaro; Tim M Strom; Martin Reincke
Journal:  Nat Genet       Date:  2013-02-17       Impact factor: 38.330

5.  A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.

Authors:  Evangelia Charmandari; Amalia Sertedaki; Tomoshige Kino; Christina Merakou; Dax A Hoffman; Michael M Hatch; Darrell E Hurt; Lin Lin; Paraskevi Xekouki; Constantine A Stratakis; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2012-05-24       Impact factor: 5.958

6.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

7.  Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3.

Authors:  Philipp Tauber; B Aichinger; C Christ; J Stindl; Y Rhayem; F Beuschlein; R Warth; S Bandulik
Journal:  Endocrinology       Date:  2016-04-01       Impact factor: 4.736

8.  Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.

Authors:  Kazutaka Nanba; Kei Omata; Tobias Else; Peter C C Beck; Aya T Nanba; Adina F Turcu; Barbra S Miller; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

9.  a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.

Authors:  Silvia Monticone; Namita G Hattangady; David Penton; Carlos M Isales; Michael A Edwards; Tracy A Williams; Christina Sterner; Richard Warth; Paolo Mulatero; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

10.  PMCA4 (ATP2B4) mutation in familial spastic paraplegia.

Authors:  Miaoxin Li; Philip Wing-Lok Ho; Shirley Yin-Yu Pang; Zero Ho-Man Tse; Michelle Hiu-Wai Kung; Pak-Chung Sham; Shu-Leong Ho
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

View more
  4 in total

Review 1.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

Review 2.  Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.

Authors:  Georgia Pitsava; Fabio R Faucz; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Curr Cardiol Rep       Date:  2022-07-16       Impact factor: 3.955

Review 3.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

Review 4.  Update on Genetics of Primary Aldosteronism.

Authors:  Kiyotaka Itcho; Kenji Oki; Haruya Ohno; Masayasu Yoneda
Journal:  Biomedicines       Date:  2021-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.